Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

20082,688 citationsJournal Articlebronze Open Access

Authors

Thomas J. Walsh · National Cancer Institute

Elias Anaissie · University of Arkansas for Medical Sciences

David W. Denning · University of Manchester

Raoul Herbrecht · Université de Strasbourg

Dimitrios P. Kontoyiannis · The University of Texas MD Anderson Cancer Center

Kieren A. Marr · Oregon Health & Science University

Vicki A. Morrison

Abstract

Aspergillus species have emerged as an important cause of life-threatening infections in immunocompromised patients. This expanding population is composed of patients with prolonged neutropenia, advanced HIV infection, and inherited immunodeficiency and patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) and/or lung transplantation. This document constitutes the guidelines of the Infectious Diseases Society of America for treatment of aspergillosis and replaces the practice guidelines for Aspergillus published in 2000 The objective of these

Topics & Keywords

Antifungal resistance and susceptibility Fungal Infections and Studies Infectious Diseases and Mycology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 46, Issue 3, pp. 327-360

DOI: 10.1086/525258

Field-Weighted Citation Impact: 121.26